Consumer

Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.

Curaleaf appoints president, marketing, digital, and brand leads; Lemon Perfect adds marketing, strategy chiefs; Nature Made, HelloFresh stir up ‘Gut Friendly’ recipes; and Thrive serves promotions for USA Pickleball.

Jim O’Neill recently was CEO of age-related diseases group SENS Research Foundation. After serving in HHS from 2002 to 2008, he became a managing director of Clarium Capital global investment fund and was Thiel Foundation CEO, funding nonprofits that promote technology.

The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful

Dietary Supplement Caucus e-launched the 119th Congress with Utah Republican House member Mike Kennedy and Texas Democrat member Marc Veasey as co-chairs and with a total of nine senators and 20 House members spanning both parties.

Czech Republic's Zentiva snaps up Aboca portfolio adding supplement brands marketed in European countries such France, Italy and Spain.

Modifications to forms FDA 3500, for voluntary reporting by healthcare professionals, and 3500A, for mandatory reporting by manufacturers, marketers or facilities, include limiting changing gender question to sex and asking for only male or female answer.

The 1,383 entries on OMUFA arrears list for facility registrations from FY2021 through FY2025 on FDA’s list exceeds its estimate of 1,134 entities subject to the fee for FY2025.

The firm doesn’t hold back on linking Muscle & Joint turmeric and tamarind formulation and Muscle & Joint + Stress also containing sceletium extract to the Tylenol brand while also pointing out that neither formulation contains acetaminophen

P&G provided sufficient support for all challenged claims, including the “Gum Detoxify” brand used on the product label and in advertising on the website and in magazine detail pages.

Complaint filed Utah federal court says “Supreme Court explicitly rejected Chevron deference to agency interpretations” in the Loper decision, compelling rejection of “an agency’s statutory interpretation unless the court, ‘after applying all relevant interpretive tools, concludes’ the interpretatio